Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGA4 | P13612 | 9/20 | 0.43 |
| ▸ | ITGB1 | P05556 | 8/20 | 0.43 |
| ▸ | ACHE | P22303 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7425014 | 0.95 | ACHE (0.46) | ITGA4ITGB1ACHEMEN1KMT2A | |
| SCHEMBL7424839 | 0.94 | ITGA4 (0.43) | ITGA4ITGB1ACHEMEN1KMT2A | |
| SCHEMBL7432383 | 0.90 | ITGB1 (0.45) | ITGA4ITGB1ACHEMEN1KMT2A | |
| SCHEMBL7425392 | 0.90 | ITGB1 (0.44) | ITGA4ITGB1ACHEMEN1KMT2A | |
| SCHEMBL7428874 | 0.88 | ACHE (0.47) | ITGA4ITGB1ACHEMEN1KMT2A | |
| SCHEMBL7430482 | 0.85 | ITGA4 (0.45) | ITGA4ITGB1MEN1KMT2AGAA | |
| SCHEMBL7426361 | 0.84 | ITGB1 (0.46) | ITGA4ITGB1MEN1KMT2AGAA | |
| SCHEMBL7393503 | 0.83 | ACHE (0.49) | ITGA4ITGB1ACHEMEN1KMT2A | |
| SCHEMBL7429580 | 0.83 | ITGB1 (0.47) | ITGA4ITGB1ACHEMEN1KMT2A | |
| SCHEMBL7431414 | 0.83 | ACHE (0.54) | ITGA4ITGB1ACHEMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999054321-A1 | SUBSTITUTED DIAMINES AND THEIR USE AS CELL ADHESION INHIBITORS | AVENTIS PHARMA LIMITED (GB) | 1999-10-28 | — | — | WO | disclosed |